Author: John Murphy, CEO The COVID-19 Long haul Foundation Abstract Objective To examine the evidence linking infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to chronic demyelinating inflammatory polyradiculoneuropathy […]
Long Covid and Depression: Neuroinflammation, Systemic Illness, and the Persistence of Affective Dysfunction
John Murphy, CEO, The COVID-19 Long-haul Foundation Review Article Abstract Long Covid, or post–COVID-19 condition, has emerged as a heterogeneous, multisystem disorder that may persist for months or years after […]
Multidisciplinary Care Pathways for Long COVID Fatigue:
A Systems-Based Model Integrating Rehabilitation Medicine, Neuroimmunology, Autonomic Care, and Precision Phenotyping Abstract Background Long COVID, also referred to as post-acute sequelae of SARS-CoV-2 infection (PASC), has emerged as one […]
Peripheral Sensory Dysfunction in Long COVID: Etiology, Genomics, Pathophysiology, Clinical Manifestations, Diagnostic Approaches, Disease Progression, and Long-Term Outcomes
John Murphy, MD., M.P.H., D.P.H., CEO, COVID-19 long-haul Foundation Abstract Long COVID, also known as Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), has emerged as one of the most significant chronic […]